Shiva Texyarn Limited promoter S K Sundararaman acquired 1,50,000 equity shares on September 9, 2026. The transaction represents a 1.16% increase in his stake relative to the total voting capital.

The acquisition was executed through an inter-se transfer of shares amongst promoters, exempting it from an open offer under Regulation 10(1)(a)(ii) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The disclosure was filed under Regulation 29(1) of the same regulations.

Transaction Details

The seller, Vedanayagam Hospital Private Ltd, reduced its holding following the sale to Sundararaman. The deal was routed through the stock exchange. The total equity share capital of the company remained unchanged at 1,29,62,713 equity shares of ₹10 each.

What the Numbers Show

The transaction consolidates promoter holdings without altering the total promoter group stake significantly. Vedanayagam Hospital Private Ltd remains the dominant shareholder with a 64.88% stake post-transfer. Sundararaman’s individual holding rose from 0.39% to 1.55%, reflecting a four-fold increase in his direct ownership relative to the diluted share capital.

Promoter S K Sundararaman will acquire 1,50,000 equity shares of Shiva Texyarn from Vedanayagam Hospital Private Limited. The inter-se transfer is scheduled for September 9, 2026.

The transaction involves the acquisition of shares representing 1.16% of the company’s total share capital. It falls under Regulation 10(1)(a) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Transaction Details

The acquisition price is determined based on the volume-weighted average market price for the 60 trading days preceding the notice issuance. The reference price stands at ₹156.56. The acquirer has declared that the final acquisition price will not exceed 25% above this computed benchmark.

Shareholding Impact

Following the transfer, S K Sundararaman’s holding will rise from 50,760 shares (0.39%) to 2,00,760 shares (1.55%). Conversely, Vedanayagam Hospital Private Limited’s stake will decrease from 85,60,466 shares (66.04%) to 84,10,466 shares (64.88%).

Regulatory Compliance

Both parties have declared compliance with Chapter V of the Takeover Regulations for the three years prior to the proposed acquisition. Additionally, both promoters submitted declarations under Regulation 31(4) confirming no encumbrance on their respective shareholdings for the financial year ended March 31, 2026.